Literature DB >> 33258403

Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK/ERK signalling pathway by downregulating microRNA-129 and microRNA-204.

Jie Chen1, Xiao Luo1, Mao Liu1, Lihui Peng1, Zixia Zhao1, Chengsong He1, Yue He2.   

Abstract

The participation of long noncoding RNAs (lncRNAs) and microRNAs (miRs) in the progression of rheumatoid arthritis (RA) is a key area of investigation. The current study aimed to investigate the action of lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) in fibroblast-like synoviocyte (FLS) proliferation and synovitis in RA. A rat model of RA was established. LncRNA NEAT1 expression in the synovial tissues of patients with RA and FLSs from the RA rat model was determined using RT-qPCR. Next, dual luciferase reporter gene assay was applied to investigate the relationship between miR-129/204 and mitogen-activated protein kinase (MAPK)/extracellular regulated protein kinase (ERK). A putative binding relationship between miR-204 and lncRNA NEAT1 was evaluated by RIP assay, and miR-129 promoter methylation was determined using MSP. After the expression of lncRNA NEAT1, miR-129 or miR-204 was altered in FLSs, the extent of ERK1/2 phosphorylation was assessed. In addition, FLS synovitis and proliferation were determined by ELISA and EdU assay, respectively. In RA rats, lncRNA NEAT1 was silenced and miR-129/miR-204 was overexpressed to explore their roles in vivo. LncRNA NEAT1 was upregulated, while miR-129 and miR-204 were downregulated in RA synovial tissues and FLSs. MAPK1 was target gene of both miR-129 and miR-204. LncRNA NEAT1 bound to miR-204 and promoted miR-129 promoter methylation. Silencing lncRNA NEAT1 or overexpressing miR-129/miR-204 enhanced miR-129/miR-204 expression, but reduced the extent of ERK1/2 phosphorylation, proliferation of FLSs, and synovitis in RA. Collectively, silencing lncRNA NEAT1 promoted miR-129 and miR-204 to inhibit the MAPK/ERK signalling pathway, reducing FLS synovitis in RA.Abbreviations: ACR: American College of Rheumatology; ELISA: Enzyme-linked immunosorbent assay; ERK: extracellular signal-regulated kinase; FLS: fibroblast-like synoviocyte; GADPH: glyceraldehyde-3-phosphate dehydrogenase; HRP: horseradish peroxidase; IFA: Incomplete Freund's Adjuvant; lncRNAs: long noncoding RNAs; MSP: Methylation-specific PCR; NC: negative control; NEAT1: nuclear paraspeckle assembly transcript 1; OD: optical density; RA: rheumatoid arthritis; RIPA: Radio Immunoprecipitation Assay; RLU: relative light units; RT-qPCR: reverse transcription quantitative polymerase chain reaction; UTR: untranslated region.

Entities:  

Keywords:  Long noncoding RNA nuclear paraspeckle assembly transcript 1; MAPK signalling pathway; fibroblast-like synoviocyte; microRNA-129; microRNA-204; rheumatoid arthritis

Mesh:

Substances:

Year:  2021        PMID: 33258403      PMCID: PMC8078539          DOI: 10.1080/15476286.2020.1857941

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  45 in total

1.  lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3.

Authors:  Ying Xia; Yu Zhou; Han Han; Peng Li; Wei Wei; Nengxing Lin
Journal:  J Cell Physiol       Date:  2019-06-07       Impact factor: 6.384

2.  NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo.

Authors:  Zhiyun He; Jie Dang; Ailin Song; Xiang Cui; Zhijun Ma; Zhongtao Zhang
Journal:  J Cell Physiol       Date:  2019-06-07       Impact factor: 6.384

3.  Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway.

Authors:  Shao-Peng Huang; Xin Guan; Guo-Yin Kai; Ya-Zhou Xu; Yuan Xu; Hao-Jie Wang; Tao Pang; Lu-Yong Zhang; Ying Liu
Journal:  Chin J Nat Med       Date:  2019-05-20

4.  Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.

Authors:  Feifei Zhang; Lingling Wu; Jie Qian; Bo Qu; Shiwei Xia; Ting La; Yanfang Wu; Jianyang Ma; Jing Zeng; Qiang Guo; Yong Cui; Wanling Yang; Jiaqi Huang; Wei Zhu; Yihong Yao; Nan Shen; Yuanjia Tang
Journal:  J Autoimmun       Date:  2016-07-29       Impact factor: 7.094

5.  Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3β pathway.

Authors:  Yini Zhang; Zhao Zhang; Haitang Wang; Nan Cai; Shuang Zhou; Yaoping Zhao; Xue Chen; Shaoqiang Zheng; Qi Si; Wei Zhang
Journal:  Mol Med Rep       Date:  2016-07-27       Impact factor: 2.952

6.  The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.

Authors:  Xuexia Zhou; Xuebing Li; Lin Yu; Run Wang; Dan Hua; Cuijuan Shi; Cuiyun Sun; Wenjun Luo; Chun Rao; Zhendong Jiang; Qian Wang; Shizhu Yu
Journal:  Int J Biochem Cell Biol       Date:  2019-06-11       Impact factor: 5.085

7.  Andrographolide Benefits Rheumatoid Arthritis via Inhibiting MAPK Pathways.

Authors:  Zun-Zhong Li; Ju-Peng Tan; Li-Li Wang; Qing-Hua Li
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

8.  Long non-coding RNA NEAT1 can predict various malignant tumour lympha node metastasis: a meta-analysis.

Authors:  Lei Zhang; Zhe Zhang; Zhenglun Yu
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

9.  Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Authors:  Annika N Alexopoulou; Maria Leao; Otavia L Caballero; Leonard Da Silva; Lynne Reid; Sunil R Lakhani; Andrew J Simpson; John F Marshall; A Munro Neville; Parmjit S Jat
Journal:  Breast Cancer Res       Date:  2010-07-19       Impact factor: 6.466

10.  LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.

Authors:  Hong-Mei Yu; Chen Wang; Zhen Yuan; Guang-Liang Chen; Tao Ye; Bi-Wei Yang
Journal:  Cell Prolif       Date:  2018-11-08       Impact factor: 6.831

View more
  8 in total

1.  Construction of a ceRNA Network Related to Rheumatoid Arthritis.

Authors:  Zhanya Huang; Nanzhen Kuang
Journal:  Genes (Basel)       Date:  2022-04-06       Impact factor: 4.141

Review 2.  Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.

Authors:  Jie Huang; Xuekun Fu; Xinxin Chen; Zheng Li; Yuhong Huang; Chao Liang
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

Review 3.  LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation.

Authors:  Wentao Huang; Xue Li; Chen Huang; Yukuan Tang; Quan Zhou; Wenli Chen
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

4.  LncRNA NEAT1 Recruits SFPQ to Regulate MITF Splicing and Control RPE Cell Proliferation.

Authors:  Xiaojuan Hu; Fang Li; Junhao He; Juan Yang; Ye Jiang; Mingyuan Jiang; Dandan Wei; Lifu Chang; J Fielding Hejtmancik; Ling Hou; Xiaoyin Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-11-01       Impact factor: 4.799

Review 5.  Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis.

Authors:  Juan-Juan Han; Xue-Qiang Wang; Xin-An Zhang
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

6.  Long Non-Coding RNA NR-133666 Promotes the Proliferation and Migration of Fibroblast-Like Synoviocytes Through Regulating the miR-133c/MAPK1 Axis.

Authors:  Nanwen Zhang; Ningning Zheng; Dunxiong Luo; Duoduo Lin; Wenzhong Que; He Wang; Qiuping Huang; Juhua Yang; Jian Ye; Xiaole Chen
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

7.  Long Non-Coding RNA PVT1 and Its Target miRNA-146a as Potential Prognostic Biomarkers in Rheumatoid Arthritis Patients.

Authors:  Randa Erfan; Olfat G Shaker; Mahmoud A F Khalil; Yumn A Elsabagh; Azza M Ahmed; Abeer K Abu-El-Azayem; Mohamed S Gomaa; Asmaa Mohammed
Journal:  Life (Basel)       Date:  2021-12-10

8.  Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.

Authors:  Kejian He; Sanshan He; Min Su
Journal:  J Clin Lab Anal       Date:  2022-01-22       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.